These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21282199)

  • 1. A common polymorphism in the human aromatase gene alters the risk for polycystic ovary syndrome and modifies aromatase activity in vitro.
    Wang H; Li Q; Wang T; Yang G; Wang Y; Zhang X; Sang Q; Wang H; Zhao X; Xing Q; Shi J; He L; Wang L
    Mol Hum Reprod; 2011 Jun; 17(6):386-91. PubMed ID: 21282199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype.
    Xita N; Lazaros L; Georgiou I; Tsatsoulis A
    Fertil Steril; 2010 Jun; 94(1):250-4. PubMed ID: 19324338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation of CYP19A1 gene in Chinese polycystic ovary syndrome patients.
    Yu YY; Sun CX; Liu YK; Li Y; Wang L; Zhang W
    Gynecol Obstet Invest; 2013; 76(4):209-13. PubMed ID: 24157654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanism for the suppression of estrogen production in polycystic ovary syndrome.
    Agarwal SK; Judd HL; Magoffin DA
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3686-91. PubMed ID: 8855823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental steroidogenesis in pregnant women with polycystic ovary syndrome.
    Maliqueo M; Lara HE; Sánchez F; Echiburú B; Crisosto N; Sir-Petermann T
    Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):151-5. PubMed ID: 23122578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of the CYP19A1 gene and breast cancer survival.
    Long JR; Kataoka N; Shu XO; Wen W; Gao YT; Cai Q; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2115-22. PubMed ID: 17119036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of Delta4-androstenedione.
    Panidis D; Kourtis A; Kukuvitis A; Farmakiotis D; Xita N; Georgiou I; Tsatsoulis A
    Hum Reprod; 2004 Aug; 19(8):1728-33. PubMed ID: 15178661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of variations in human P450 oxidoreductase on the aromatase activity of CYP19A1 polymorphisms R264C and R264H.
    Parween S; DiNardo G; Baj F; Zhang C; Gilardi G; Pandey AV
    J Steroid Biochem Mol Biol; 2020 Feb; 196():105507. PubMed ID: 31669572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome.
    Söderlund D; Canto P; Carranza-Lira S; Méndez JP
    Hum Reprod; 2005 Apr; 20(4):965-9. PubMed ID: 15695318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic association study from North India to analyze association of CYP19A1 and CYP17A1 with polycystic ovary syndrome.
    Kaur R; Kaur T; Kaur A
    J Assist Reprod Genet; 2018 Jun; 35(6):1123-1129. PubMed ID: 29564739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels.
    Barber TM; Bennett AJ; Gloyn AL; Groves CJ; Sovio U; Ruokonen A; Martikainen H; Pouta A; Taponen S; Weedon MN; Hartikainen AL; Wass JA; Järvelin MR; Zeggini E; Franks S; McCarthy MI
    Eur J Hum Genet; 2007 Jun; 15(6):679-84. PubMed ID: 17342155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase enzyme and Alzheimer's disease.
    Hiltunen M; Iivonen S; Soininen H
    Minerva Endocrinol; 2006 Mar; 31(1):61-73. PubMed ID: 16498364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of steroid metabolic enzymes in secretory endometria from untreated women with Polycystic Ovary Syndrome.
    Leon L; Bacallao K; Gabler F; Romero C; Valladares L; Vega M
    Steroids; 2008 Jan; 73(1):88-95. PubMed ID: 17953976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of intermediates and isotopically sensitive enolization distinguish between aromatase (cytochrome P450 CYP19) from rat ovary and human placenta.
    Swinney DC; Watson DM; So OY
    Arch Biochem Biophys; 1993 Aug; 305(1):61-7. PubMed ID: 8342956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulosa cell aromatase enzyme activity: effects of follicular fluid from patients with polycystic ovary syndrome, using aromatase conversion and [11C]vorozole-binding assays.
    Kirilovas D; Chaika A; Bergström M; Bergström-Petterman E; Carlström K; Nosenko J; Korniyenko S; Yakovets A; Mogilevkina I; Naessen T
    Gynecol Endocrinol; 2006 Dec; 22(12):685-91. PubMed ID: 17162711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro kinetic properties of the Thr201Met variant of human aromatase gene CYP19A1: functional responses to substrate and product inhibition and enzyme inhibitors.
    Payne EJ; Ingley E; Dick IM; Wilson SG; Bond CS; Prince RL
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2998-3002. PubMed ID: 19470632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of AR rs6152G/A gene polymorphism with susceptibility to polycystic ovary syndrome in Chinese women.
    Peng CY; Long XY; Lu GX
    Reprod Fertil Dev; 2010; 22(5):881-5. PubMed ID: 20450840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A microsatellite polymorphism (tttta)n in the promoter of the CYP11a gene in Chinese women with polycystic ovary syndrome.
    Wang Y; Wu X; Cao Y; Yi L; Chen J
    Fertil Steril; 2006 Jul; 86(1):223-6. PubMed ID: 16764871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association study between a polymorphism of aldosterone synthetase gene and the pathogenesis of polycystic ovary syndrome].
    Zhao SP; Tang XM; Shao DH; Dai HY; Dai SZ
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):94-7. PubMed ID: 12783697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol 3-kinase p85alpha regulatory subunit gene Met326Ile polymorphism in women with polycystic ovary syndrome.
    Kim JJ; Choi YM; Hong MA; Hwang SS; Yoon SH; Chae SJ; Jee BC; Ku SY; Kim JG; Moon SY
    Hum Reprod; 2009 May; 24(5):1184-90. PubMed ID: 19218574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.